Preclinical evaluation of ex vivo expanded/activated γδ T cells for immunotherapy of glioblastoma multiforme

Journal of Neuro-Oncology

Volumn 101, Issue 2, 2011, Pages 179-188

  Bryant, Nichole L ^a   Gillespie, G Yancey ^a   Lopez, Richard D ^a   Markert, James M ^a   Cloud, Gretchen A ^a   Langford, Catherine P ^a   Arnouk, Hilal ^a   Su, Yun ^a   Haines, Hilary L ^a   Suarez Cuervo, Catalina ^a   Lamb Jr , Lawrence S ^a  

^a UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

Author keywords

T cells; Brain tumor; Cellular therapy; Glioblastoma multiforme; Immunotherapy; T cells

Indexed keywords

CD2 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; NATURAL KILLER CELL RECEPTOR NKG2D; OKT 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER IMMUNOTHERAPY; CELL EXPANSION; CELL MEDIATED CYTOTOXICITY; CONTROLLED STUDY; EX VIVO STUDY; GAMMA DELTA T LYMPHOCYTE; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE SUBPOPULATION; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; SURVIVAL TIME; T LYMPHOCYTE ACTIVATION; TH1 CELL; THERAPY EFFECT; TUMOR CELL CULTURE; TUMOR GROWTH; TUMOR MICROENVIRONMENT; TUMOR XENOGRAFT;

ANIMALS; ANTIGENS, CD; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; GLIOBLASTOMA; GPI-LINKED PROTEINS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, NUDE; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; SURVIVAL ANALYSIS; T-LYMPHOCYTES; TIME FACTORS; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 78651291782     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-010-0245-2     Document Type: Article

References (41)

1. MG Castro R Cowen IK Williamson A David MJ Jimenez-Dalmaroni X Yuan A Bigliari JC Williams J Hu PR Lowenstein 2003 Current and future strategies for the treatment of malignant brain tumors Pharmacol Ther 98 71 108 1:CAS:528:DC%2BD3sXit12nsbk%3D 12667889 10.1016/S0163-7258(03)00014-7 (Pubitemid 36349762)
2. A Boiardi A Silvani PA Ruffini L Rivoltini G Parmiani G Broggi A Salmaggi 1994 Loco-regional immunotherapy with recombinant interleukin-2 and adherent lymphokine-activated killer cells (A-LAK) in recurrent glioblastoma patients Cancer Immunol Immunother 39 193 197 1:STN:280:DyaK2M%2FgslKntw%3D%3D 7923250 10.1007/BF01533386
3. JS Yu G Liu H Ying WH Yong KL Black CJ Wheeler 2004 Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma Cancer Res 64 4973 4979 1:CAS:528: DC%2BD2cXls1Omt7o%3D 15256471 10.1158/0008-5472.CAN-03-3505 (Pubitemid 38924545)
4. RE Merchant NG Baldwin CD Rice HD Bear 1997 Adoptive immunotherapy of malignant glioma using tumor-sensitized T lymphocytes Neurol Res 19 145 152 1:STN:280:DyaK2szhvVWlsg%3D%3D 9175143
5. GE Plautz GH Barnett DW Miller BH Cohen RA Prayson JC Krauss M Luciano DB Kangisser S Shu 1998 Systemic T cell adoptive immunotherapy of malignant gliomas J Neurosurg 89 42 51 1:STN:280:DyaK1czgvFertA%3D%3D 9647171 10.3171/jns.1998.89.1.0042
6. RE Merchant MD Ellison HF Young 1990 Immunotherapy for malignant glioma using human recombinant interleukin-2 and activated autologous lymphocytes. A review of pre-clinical and clinical investigations J Neurooncol 8 173 188 1:STN:280:DyaK3c3ptlygtg%3D%3D 2193121 10.1007/BF00177842
7. D Barba SC Saris C Holder SA Rosenberg EH Oldfield 1989 Intratumoral LAK cell and interleukin-2 therapy of human gliomas J Neurosurg 70 175 182 1:STN:280:DyaL1M7htVChtw%3D%3D 2643685 10.3171/jns.1989.70.2.0175
8. SC Saris NJ Patronas SA Rosenberg JT Alexander J Frank DJ Schwartzentruber JT Rubin D Barba EH Oldfield 1989 The effect of intravenous interleukin-2 on brain water content J Neurosurg 71 169 174 1:STN:280: DyaL1MzhtVOjtA%3D%3D 2787395 10.3171/jns.1989.71.2.0169
9. RL Hayes M Koslow EM Hiesiger KB Hymes HS Hochster EJ Moore DM Pierz DK Chen GN Budzilovich J Ransohoff 1995 Improved long term survival after intracavitary interleukin-2 and lymphokine-activated killer cells for adults with recurrent malignant glioma Cancer 76 840 852 1:CAS:528:DyaK2MXosVejsLY%3D 8625188 10.1002/1097-0142(19950901)76:5<840::AID-CNCR2820760519>3.0.CO;2-R
10. RO Dillman CM Duma PM Schiltz C DePriest RA Ellis K Okamoto LD Beutel C De Leon S Chico 2004 Intracavitary placement of autologous lymphokine-activated killer (LAK) cells after resection of recurrent glioblastoma J Immunother 27 398 404 15314549 10.1097/00002371-200409000-00009
11. KB Quattrocchi CH Miller S Cush SA Bernard ST Dull M Smith S Gudeman MA Varia 1999 Pilot study of local autologous tumor infiltrating lymphocytes for the treatment of recurrent malignant gliomas J Neurooncol 45 141 157 1:STN:280:DC%2BD3c3jvFSjsw%3D%3D 10778730 10.1023/A:1006293606710 (Pubitemid 30197728)
12. CA Kruse L Cepeda B Owens SD Johnson J Stears KO Lillehei 1997 Treatment of recurrent glioma with intracavitary alloreactive cytotoxic T lymphocytes and interleukin-2 Cancer Immunol Immunother 45 77 87 1:CAS:528:DyaK2sXotVOju7k%3D 9390198 10.1007/s002620050405 (Pubitemid 27497682)
13. SB Read NV Kulprathipanja GG Gomez DB Paul KR Winston JM Robbins CA Kruse 2003 Human alloreactive CTL interactions with gliomas and with those having upregulated HLA expression from exogenous IFN-gamma or IFN-gamma gene modification J Interferon Cytokine Res 23 379 393 1:CAS:528:DC%2BD3sXmtV2ns7k%3D 14511464 10.1089/107999003322226032 (Pubitemid 36876284)
14. F Komatsu M Kajiwara 2000 CD18/CD54 (+CD102), CD2/CD58 pathway-independent killing of lymphokine-activated killer (LAK) cells against glioblastoma cell lines T98G and U373MG Oncol Res 12 17 24 1:CAS:528: DC%2BD3cXnsVClu74%3D 11061342
15. J Wischhusen MA Friese M Mittelbronn R Meyermann M Weller 2005 HLA-E protects glioma cells from NKG2D-mediated immune responses in vitro: implications for immune escape in vivo J Neuropathol Exp Neurol 64 523 528 1:CAS:528:DC%2BD2MXlvVSgtro%3D 15977644
16. H Wiendl M Mitsdoerffer V Hofmeister J Wischhusen A Bornemann R Meyermann EH Weiss A Melms M Weller 2002 A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape J Immunol 168 4772 4780 1:CAS:528:DC%2BD38Xjt12jurg%3D 11971028
17. G Hacker S Kromer M Falk K Heeg H Wagner KV Pfeffer 1992 Delta 1+ subset of human gamma delta T cells responds to ligands expressed by EBV-infected Burkitt lymphoma cells and transformed B lymphocytes J Immunol 149 3984 3989 1:STN:280:DyaK3s%2FpsVGqtg%3D%3D 1334108
18. Bryant NL, Suarez-Cuervo C, Gillespie GY, Markert JM, Nabors LB, Meleth S, Lopez RD, Lamb LS Jr (2009) Characterization and immunotherapeutic potential of {gamma}{delta} T cells in patients with glioblastoma. Neuro-Oncology 11:357-367
19. M Girardi DE Oppenheim CR Steele JM Lewis E Glusac R Filler P Hobby B Sutton RE Tigelaar AC Hayday 2001 Regulation of cutaneous malignancy by gamma delta T cells Science 294 605 609 1:CAS:528:DC%2BD3MXnslOmtbs%3D 11567106 10.1126/science.1063916 (Pubitemid 32999559)
20. Z Liu IE Eltoum B Guo BH Beck GA Cloud RD Lopez 2008 Protective immunosurveillance and therapeutic antitumor activity of gamma delta T cells demonstrated in a mouse model of prostate cancer J Immunol 180 6044 6053 1:CAS:528:DC%2BD1cXkvVCjsLg%3D 18424725
21. M Ferrarini SM Pupa MR Zocchi C Rugarli S Menard 1994 Distinct pattern of HSP72 and monomeric laminin receptor expression in human lung cancers infiltrated by gamma/delta T lymphocytes Int J Cancer 57 486 490 1:STN:280:DyaK2c3jslGquw%3D%3D 7514151 10.1002/ijc.2910570408 (Pubitemid 24173091)
22. A Choudhary F Davodeau A Moreau MA Peyrat M Bonneville F Jotereau 1995 Selective lysis of autologous tumor cells by recurrent gamma delta tumor-infiltrating lymphocytes from renal carcinoma J Immunol 154 3932 3940 1:CAS:528:DyaK2MXkvFOrtb0%3D 7706731
23. X Zhao YQ Wei Y Kariya K Teshigawara A Uchida 1995 Accumulation of gamma/delta T cells in human dysgerminoma and seminoma: roles in autologous tumor killing and granuloma formation Immunol Investig 24 607 618 1:STN:280:DyaK2MzkslOktA%3D%3D 10.3109/08820139509066861
24. M Bagot M Heslan L Dubertret JC Roujeau R Tourine JP Levy 1985 Antigen presenting properties of human epidermal cells compared with peripheral blood mononuclear cells Br J Dermatol 113 Suppl 28 55 2410006 10.1111/j.1365-2133. 1985.tb15626.x (Pubitemid 15012572)
25. Y Fujimiya Y Suzuki R Katakura T Miyagi T Yamaguchi T Yoshimoto T Ebina 1997 In vitro interleukin 12 activation of peripheral blood CD3(+)CD56(+) and CD3(+)CD56(-) gamma delta T cells from glioblastoma patients Clin Cancer Res 3 633 643 1:CAS:528:DyaK2sXislGitbs%3D 9815731
26. T Yamaguchi Y Suzuki R Katakura T Ebina J Yokoyama Y Fujimiya 1998 Interleukin-15 effectively potentiates the in vitro tumor-specific activity and proliferation of peripheral blood gamma delta T cells isolated from glioblastoma patients Cancer Immunol Immunother 47 97 103 1:CAS:528:DyaK1cXmvFWku7s%3D 9769118 10.1007/s002620050509 (Pubitemid 28443560)
27. RD Lopez S Xu B Guo RS Negrin EK Waller 2000 CD2-mediated IL-12-dependent signals render human gamma-delta T cells resistant to mitogen-induced apoptosis, permitting the large-scale ex vivo expansion of functionally distinct lymphocytes: implications for the development of adoptive immunotherapy strategies Blood 96 3827 3837 1:CAS:528:DC%2BD3cXosVGntbs%3D 11090067
28. B Guo K Hollmig RD Lopez 2002 Down-regulation of IL-2 receptor a (CD25) characterizes human gd-T cells rendered resistant to apoptosis after CD2 engagement in the presence of IL-12 Cancer Immunol Immunother 50 625 637 1:CAS:528:DC%2BD38XhsVens7g%3D 11807626 10.1007/s00262-001-0244-4
29. MA Friese M Platten SZ Lutz U Naumann S Aulwurm F Bischof HJ Buhring J Dichgans HG Rammensee A Steinle M Weller 2003 MICA/NKG2D-mediated immunogene therapy of experimental gliomas Cancer Res 63 8996 9006 1:CAS:528: DC%2BD3sXhtVSqtbbK 14695218
30. M Otto RC Barfield R Iyengar J Gatewood I Muller MS Holladay J Houston W Leung R Handgretinger 2005 Human gamma delta T cells from G-CSF-mobilized donors retain strong tumoricidal activity and produce immunomodulatory cytokines after clinical-scale isolation J Immunother 28 73 78 1:CAS:528:DC%2BD2cXhtFeju7zE 15614047 10.1097/00002371-200501000-00009
31. E Radaelli R Ceruti V Patton M Russo A Degrassi V Croci F Caprera G Stortini E Scanziani E Pesenti R Alzani 2009 Immunohistopathological and neuroimaging characterization of murine orthotopic xenograft models of glioblastoma multiforme recapitulating the most salient features of human disease Histol Histopathol 24 879 891 1:CAS:528:DC%2BD1MXhtVahsr3M 19475534
32. MJ Kaminski PD Cruz Jr PR Bergstresser A Takashima 1993 Killing of skin-derived tumor cells by mouse dendritic epidermal T-cells Cancer Res 53 4014 4019 1:STN:280:DyaK3szmsV2jsg%3D%3D 8358730 (Pubitemid 23267704)
33. V Groh A Steinle S Bauer T Spies 1998 Recognition of stress-induced MHC molecules by intestinal epithelial gamma delta T cells Science 279 1737 1740 1:CAS:528:DyaK1cXhvVers78%3D 9497295 10.1126/science.279.5357.1737 (Pubitemid 28164472)
34. J Wu V Groh T Spies 2002 T cell antigen receptor engagement and specificity in the recognition of stress-inducible MHC class I-related chains by human epithelial gamma delta T cells J Immunol 169 1236 1240 1:CAS:528:DC%2BD38XlslWhsL0%3D 12133944
35. CT Morita RA Mariuzza MB Brenner 2000 Antigen recognition by human gamma delta T cells: pattern recognition by the adaptive immune system Springer Semin Immunopathol 22 191 217 1:CAS:528:DC%2BD3cXnslGjtLc%3D 11116953 10.1007/s002810000042
36. S Bauer V Groh J Wu A Steinle JH Phillips LL Lanier T Spies 1999 Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA [see comments] Science 285 727 729 1:CAS:528:DyaK1MXltVehsro%3D 10426993 10.1126/science.285.5428.727 (Pubitemid 29484539)
37. V Groh R Rhinehart H Secrist S Bauer KH Grabstein T Spies 1999 Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB Proc Natl Acad Sci USA 96 6879 6884 1:CAS:528: DyaK1MXks1Wktro%3D 10359807 10.1073/pnas.96.12.6879 (Pubitemid 29274978)
38. RL O'Brien CL Roark N Jin MK Aydintug JD French JL Chain JM Wands M Johnston WK Born 2007 Gamma delta T-cell receptors: functional correlations Immunol Rev 215 77 88 17291280 10.1111/j.1600-065X.2006.00477.x (Pubitemid 46212231)
39. R Castriconi A Daga A Dondero G Zona PL Poliani A Melotti F Griffero D Marubbi R Spaziante F Bellora L Moretta A Moretta G Corte C Bottino 2009 NK cells recognize and kill human glioblastoma cells with stem cell-like properties J Immunol 182 3530 3539 1:CAS:528:DC%2BD1MXis12itL0%3D 19265131 10.4049/jimmunol.0802845
40. M Ferrarini F Delfanti M Gianolini C Rizzi M Alfano A Lazzarin P Biswas 2008 NF-kappa B modulates sensitivity to apoptosis, proinflammatory and migratory potential in short- versus long-term cultured human gamma delta lymphocytes J Immunol 181 5857 5864 1:CAS:528:DC%2BD1cXht1Krtr3I 18941174
41. YH Gan M Wallace M Malkovsky 2001 Fas-dependent, activation-induced cell death of gamma delta cells J Biol Regul Homeost Agents 15 277 285 1:CAS:528:DC%2BD3MXovFShurs%3D 11693437